New York A11628 mandates insurance policies to cover FDA-approved expanded access to effective investigational medical products without prior.

New York A11628 amends the insurance law to require medical, major medical, or similar comprehensive type coverage to include federal food and drug administration approved expanded access to investigational medical products shown to be effective. This coverage must be provided without the need for any prior authorization determination. The act applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the effective date.

New York A11628 mandates insurance policies to cover FDA-approved expanded access to effective investigational medical products without prior.

New York A11628 amends the insurance law to require medical, major medical, or similar comprehensive type coverage to include federal food and drug administration approved expanded access to investigational medical products shown to be effective. This coverage must be provided without the need for any prior authorization determination. The act applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the effective date.